These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24790054)

  • 21. [Arterial Hypertension - when are which combination therapies useful?].
    Brenner R; Rimoldi SF; Rexhaj E; Allemann Y
    Ther Umsch; 2012 May; 69(5):305-13. PubMed ID: 22547363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New drug therapies interfering with the renin-angiotensin-aldosterone system for resistant hypertension.
    Monge M; Lorthioir A; Bobrie G; Azizi M
    J Renin Angiotensin Aldosterone Syst; 2013 Dec; 14(4):285-9. PubMed ID: 24222656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel strategies and targets for the management of hypertension.
    Taylor DA; Abdel-Rahman AA
    Adv Pharmacol; 2009; 57():291-345. PubMed ID: 20230765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a future for direct renin inhibitors?
    Chaudhary K; Nistala R; Whaley-Connell A
    Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antihypertensive drugs in 2010: old and new agents].
    Leeman M
    Rev Med Brux; 2010 Sep; 31(4):345-9. PubMed ID: 21089413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hypertension with fixed-dose triple-combination treatments.
    Epstein BJ; Shah NK; Borja-Hart NL
    Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
    Lazich I; Bakris GL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-of-the-art treatment of hypertension: established and new drugs.
    Burnier M; Vuignier Y; Wuerzner G
    Eur Heart J; 2014 Mar; 35(9):557-62. PubMed ID: 24216391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive Combination Treatment: State of the Art.
    Burnier M
    Curr Hypertens Rep; 2015 Jul; 17(7):51. PubMed ID: 26068654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New emerging prospects in the pharmacotherapy of hypertension.
    Balsamo A; Calderone V; Rapposelli S
    Cardiovasc Hematol Agents Med Chem; 2008 Jan; 6(1):1-19. PubMed ID: 18220718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Pathophysiological Mechanisms in Hypertension.
    Samson R; Lee A; Lawless S; Hsu R; Sander G
    Adv Exp Med Biol; 2017; 956():21-35. PubMed ID: 27981434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview.
    Naik P; Gandhi H; Pawar V; Giridhar R; Yadav MR
    Curr Clin Pharmacol; 2015; 10(4):321-46. PubMed ID: 24117126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension.
    Volpe M
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S1. PubMed ID: 26153400
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel Therapies on the Horizon of Hypertension Management.
    Blazek O; Bakris GL
    Am J Hypertens; 2023 Feb; 36(2):73-81. PubMed ID: 36201204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.